I'm calling it bullshit (and have for a long time). CYDY is a fraudy biotech which does these constant press releases with misleading data. PairTheBoard was sucked in and promoting it endlessly on here to big losses for lots of people (sad to see a math guy go full blown ****** on a bio scam, i even called him out earlier ITT).
The key to the bullshit is here:
Quote:
At Day 3, more subjects treated with leronlimab reported improvement in total clinical symptom score compared to the placebo group (90% on leronlimab arm vs. 71% on placebo). The subgroup analysis indicates that among patients with more symptoms at baseline, those who received leronlimab had a greater treatment effect than patients who received the placebo.
90% vs 71% is a terrible number for "mild to moderate". No one will bother using it. Especially since endpoints seem cherry picked/data snooped:
Quote:
Similar, statistically significant, results were observed at Day 3 and Day 14 in the analysis of per protocol population (p<0.03 and p<0.02, respectively).
I love the weasel language here:
Quote:
In all treated patients, at the End of Treatment (or Day 14), patients in the leronlimab group were more than twice as likely to experience a beneficial improvement in scores compared to patients in the placebo group (50% vs 20%; p=0.0223).
How much is this "beneficial improvement"? A 1 point clinical symptom score improvement would satisfy this and also make it useless for real world use (especially since these are "mild to moderate" and not severe.
And what does a "greater treatment effect" mean? There's no quantification of magnitude or even what the score was.
There's nothing to see except data snooping and dishonest press releases imo.